Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
ASML Holding N.V. (NASDAQ: ASML) shares increased 1.68 percent to close at $97.71 a share Thursday. The stock traded between $96.55 and $97.82 on volume of 1.06 million shares traded. Analysts at Susquehanna have recently downgraded the company’s rating to "neutral" from "positive". Shares of ASML have gained approximately 27.0 percent year-to-date.
Find out more about ASML including full access to the free equity report at:
DaVita HealthCare Partners Inc. (NYSE: DVA) shares increased 1.32 percent to close at $58.12 a share Thursday. The stock traded between $57.61 and $58.16 on volume of 933,801 traded. Analysts at Atlantic Equities have recently initiated coverage on the company with an "overweight" rating and a price target of $68.00. Shares of DaVita HealthCare Partners have gained approximately 30.0 percent year-to-date.
Find out more about DaVita HealthCare Partners including full access to the free equity report at:
Maxim Integrated Products Inc. (NASDAQ: MXIM) shares increased 1.13 percent to close at $29.55 a share Thursday. The stock traded between $29.20 and $29.76 on volume of 2.62 million shares traded. Analysts at Nomura have recently downgraded the company’s rating to "neutral" from "buy".
Find out more about Maxim Integrated Products including full access to the free equity report at:
Philip Morris International Inc. (NYSE: PM) shares gained 2.38 percent to close at $86.16 a share Thursday. The stock traded between $84.80 and $86.20 on volume of 5.83 million shares traded. Analysts at Nomura have recently downgraded the company’s rating to "reduce" from "neutral". Shares of Philip Morris International have gained approximately 3.0 percent year-to-date.
Find out more about Philip Morris International including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing
Leave a comment...